1. Home
  2. AVXL vs YRD Comparison

AVXL vs YRD Comparison

Compare AVXL & YRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVXL
  • YRD
  • Stock Information
  • Founded
  • AVXL 2004
  • YRD 2012
  • Country
  • AVXL United States
  • YRD China
  • Employees
  • AVXL N/A
  • YRD N/A
  • Industry
  • AVXL Biotechnology: Biological Products (No Diagnostic Substances)
  • YRD Finance: Consumer Services
  • Sector
  • AVXL Health Care
  • YRD Finance
  • Exchange
  • AVXL Nasdaq
  • YRD Nasdaq
  • Market Cap
  • AVXL 794.0M
  • YRD 584.1M
  • IPO Year
  • AVXL N/A
  • YRD 2015
  • Fundamental
  • Price
  • AVXL $9.32
  • YRD $6.04
  • Analyst Decision
  • AVXL Strong Buy
  • YRD
  • Analyst Count
  • AVXL 2
  • YRD 0
  • Target Price
  • AVXL $44.00
  • YRD N/A
  • AVG Volume (30 Days)
  • AVXL 927.5K
  • YRD 144.2K
  • Earning Date
  • AVXL 08-05-2025
  • YRD 06-12-2025
  • Dividend Yield
  • AVXL N/A
  • YRD 7.29%
  • EPS Growth
  • AVXL N/A
  • YRD N/A
  • EPS
  • AVXL N/A
  • YRD 2.13
  • Revenue
  • AVXL N/A
  • YRD $824,411,631.00
  • Revenue This Year
  • AVXL N/A
  • YRD N/A
  • Revenue Next Year
  • AVXL N/A
  • YRD N/A
  • P/E Ratio
  • AVXL N/A
  • YRD $2.76
  • Revenue Growth
  • AVXL N/A
  • YRD 13.14
  • 52 Week Low
  • AVXL $4.00
  • YRD $4.12
  • 52 Week High
  • AVXL $14.44
  • YRD $9.20
  • Technical
  • Relative Strength Index (RSI)
  • AVXL 60.62
  • YRD 42.73
  • Support Level
  • AVXL $9.09
  • YRD $5.90
  • Resistance Level
  • AVXL $9.78
  • YRD $6.12
  • Average True Range (ATR)
  • AVXL 0.41
  • YRD 0.27
  • MACD
  • AVXL 0.09
  • YRD -0.06
  • Stochastic Oscillator
  • AVXL 71.58
  • YRD 7.98

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical-stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system diseases with high unmet need. It analyzes genomic data from clinical studies to identify biomarkers, which are further used in the analysis of clinical trials. The company's focus is on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its various therapeutic candidates in different stages of development include Anavex 2-73 (Blacamesine), Anavex 3-71 (AF710B), Anavex 1-41, and Anavex 1066.

About YRD Yiren Digital Ltd.

Yiren Digital Ltd is an AI-powered platform providing a comprehensive suite of financial and lifestyle services in China. Its mission is to elevate customers' financial well-being and enhance their quality of life by delivering digital financial services, tailor-made insurance solutions, and premium lifestyle services. The company supports clients at various growth stages, addressing financing needs arising from consumption and production activities, while aiming to augment the overall well-being and security of individuals, families, and businesses.

Share on Social Networks: